2 ms·
Exactly. Insurance companies are very interested in Real World Data (RWD) around genomic based treatments. By using those data they can have a better sense of w
by jghn 5y ago
Exactly. Insurance companies are very interested in Real World Data (RWD) around genomic based treatments. By using those data they can have a better sense of which patients would be likely to respond to which drugs, and steer treatment that way.
- Gibbon1 5y agoThere another reason for genomic tests they also rule out the need for treatment. Either the tumor is benign or very low grade cancer.